ADAR1 Capital Management, LLC, 10% Owner at InMed Pharmaceuticals Inc. (INM), bought 9,569 shares at $1.33 ($13K) on 2026-10-13, disclosed to the SEC on 2026-10-15.
Open-market purchase of $13k INM by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.33 | 564 | $750 | 5.9% |
| 2 | $1.33 | 8,021 | $11K | 83.9% |
| 3 | $1.32 | 984 | $1K | 10.2% |
| Total | $1.33 avg | 9,569 | $13K | 100% |
| Filing → |
| INM | BUY | 2026-09-16 | $118K | — | Filing → |
| TENX | BUY | 2026-09-08 | $1.6M | — | Filing → |
| TENX | BUY | 2026-09-02 | $1.4M | — | Filing → |